ARCHIVES

Blincyto Demonstrates Response In Minimal Residual Disease ALL

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Memantine Can Delay Onset Of Cognitive Function Decline

November 30, 2012

Letters To The Editor From I-ELCAP’s Claudia Henschke and Steve Walker From Abigail Alliance.

July 8, 2011

With workload Up, Oncology Division To Add More Staff

August 2, 1996

Army of Women, caBIG To Collaborate.

August 7, 2009

Higher Tobacco Tax Will Save Lives, Groups Tell Clinton, congress

January 22, 1993

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011